About Cameron Nelson
Cameron Nelson is a chief financial officer at Mati Therapeutics.
Cameron Nelson reports to the SEC as an officer of 1 public company: Novelion Therapeutics (NVLNF).
Cameron Nelson first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Cameron Nelson in the role, so the role may have started earlier or lasted longer.
Mati Therapeutics Inc.
Chief Financial Officer
2013 – 2026 · Austin, TX
Develops a device that delivers medication to people with eye diseases.
NI
Novelion Therapeutics Inc.
Senior VP, Finance and CFO
2006 – 2011 · Public company (NVLNF)
Key Colleagues at Startups
The people Cameron Nelson works with at each company, as listed on that company's latest Form D.
Mati Therapeutics Inc. · Form D/A, Jul 2, 2026
LL
Linda Lupini
Director
JM
Jim Mazzo
Director
KJ
Ken Jones
Director
DF
Dave Fellows
Director
PM
Peter McDonnell
Director
Christopher Muller
Chief Operating Officer and director
Robert Butchofsky
Chief Executive Officer and director
JI
Joseph Tortorice III
Director